Distribution and secretory pathways of prostate specific antigen, α1-antichymotrypsin and prostate secretory granules in prostate cancers

Pathology International

Volumn 53, Issue 7, 2003, Pages 415-421

  Ishida, Eiwa ^a   Nakamura, Mitsutoshi ^a   Shimada, Keiji ^a   Kishi, Munehiro ^a   Nakaoka, Shingo ^a   Konishi, Noboru ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

1 antichymotrypsin; Complexed prostate specific antigen; Free prostate specific antigen; Immunohistochemistry; Prostate cancer; Prostate secretory granules

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; GLUTARALDEHYDE; PROSTATE SPECIFIC ANTIGEN; PROSTATIC SECRETORY PROTEIN;

ANALYSIS OF VARIANCE; ARTICLE; CANCER SCREENING; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATECTOMY; PROTEIN SECRETION; SCORING SYSTEM; TISSUE FIXATION; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ALPHA 1-ANTICHYMOTRYPSIN; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; SECRETORY VESICLES;

EID: 0041731810     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01499.x     Document Type: Article

References (24)

1. Wang MC, Papsidero LD, Kuriyama M et al. Prostate antigen: a new potential marker for prostatic cancer. Prostate 1981; 2: 89-96.
2. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985; 76: 1899-903.
3. Watt KW, Lee PJ, M'Timkulu T et al. Human prostate-specific antigen: structural and functional similarity with serine proteases. Proc Natl Acad Sci U S A 1986; 83: 3166-70.
4. Lilja H, Oldbring J, Rannevik G et al. Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen. J Clin Invest 1987; 80: 281-5.
5. Stamey TA, Yang N, Hay AR et al. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987; 317: 909-16.
6. Hudson MA, Bahnson RR, Catalona WJ. Clinical use of prostate specific antigen in patients with prostate cancer. J Urol 1989; 142: 1011-17.
7. Catalona WJ, Smith DS, Ratliff TL et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324: 1156-61.
8. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990; 194: 755-63.
9. Stenman UH, Leinonen J, Alfthan H et al. A complex between prostate-specific antigen and alpha 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991; 51: 222-6.
10. Catalona WJ, Smith DS. Comparison of different serum prostate specific antigen measures for early prostate cancer detection. Cancer 1994; 74: 1516-18.
11. Luderer AA, Chen YT, Soriano TF et al. Measurement of the proportion of free to total prostate-specific antigen improves diagnostic performance of prostate-specific antigen in the diagnostic gray zone of total prostate-specific antigen. Urology 1995; 46: 187-94.
12. Egawa S, Soh S, Ohori M et al. The ratio of free to total serum prostate specific antigen and its use in differential diagnosis of prostate carcinoma in Japan. Cancer 1997; 79: 90-98.
13. Cohen RJ, McNeal JE, Edgar SG et al. Characterization of cytoplasmic secretory granules (PSG), in prostatic epithelium and their transformation-induced loss in dysplasia and adenocarcinoma. Hum Pathol 1998; 29: 1488-94.
14. Cohen RJ, McNeal JE, Redmond SL et al. Luminal contents of benign and malignant prostatic glands: correspondence to altered secretory mechanisms. Hum Pathol 2000; 31: 94-100.
15. Cohen RJ, Beales MP, McNeal JE. Prostate secretory granules in normal and neoplastic prostate glands: a diagnostic aid to needle biopsy. Hum Pathol 2000; 31: 1515-19.
16. Matsumoto K, Konishi N, Samori T et al. ELISA for a complexed antigen with a monoclonal antibody blocking reaction with the free antigen-assay-specific for complexed prostate-specific antigen. J Immunol Meth 2000; 234: 99-106.
17. Matsumoto K, Konishi N, Hiasa Y et al. A highly sensitive enzyme-linked immunoassay for serum free prostate specific antigen (f-PSA). Clin Chim Acta 1999; 281: 57-69.
18. Huber PR, Mattarelli G, Strittmatter B et al. In vivo and in vitro complex formation of prostate specific antigen with alpha 1-anti-chymotrypsin. Prostate 1995; 27: 166-75.
19. Ornstein DK, Englert C, Gillespie JW et al. Characterization of intracellular prostate-specific antigen from laser capture micro-dissected benign and malignant prostatic epithelium. Clin Cancer Res 2000; 6: 353-6.
20. Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52: 655-709.
21. Tanaka M, Suzuki Y, Takaoka K et al. Immunohistochemical finding of alpha-1-antichymotrypsin in tissues of benign prostatic hyperplasia and prostate cancer. Int J Urol 1999; 6: 600-606.
22. Wu G, Lilja H, Cockett AT et al. Cloning and characterization of the alpha 1-antichymotrypsin produced by human prostate tissue. Prostate 1998; 34: 155-61.
23. Chen Z, Chen H, Stamey TA. Monoclonal antibodies 2F5 and 4G10 against prostate specific antigen (PSA) complexed to alpha1-antichymotrypsin. J Urol 1998; 160: 870-75.
24. Lilja H, Christensson A, Dahlen U et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 1991; 37: 1618-25.